doi: 10.1093/humrep/dem035 100 SteegJSteuresPEijkemansMHabbemaJHompesPBurggraaffJet al
Verdich C, Flint A, Gutzwiller JP, Nslund E, Beglinger C, Hellstrm PM, Long SJ, Morgan LM, Holst JJ, Astrup A
Receive your results faster within days rather than weeks
When your intended dose is already small, losing 20 to 30 percent of that dose to degradation can push you below the therapeutic threshold entirely
Despite the strength in the large cumulative sample size and compilation of data from the statistically robust design of RCTs, one of the major limitations of meta-analysis studies for retinopathy is the lack of standardization in reporting and detecting retinopathy across the included trials